<DOC>
	<DOC>NCT01689090</DOC>
	<brief_summary>The primary objective is to study if an inhibition of nitric oxide and/or prostaglandins affect the diameter changes of retinal vessels observed during hypoxia. Diameter changes are studied using the Dynamic Vessel Analyzer.</brief_summary>
	<brief_title>Diameter Changes of Retinal Vessels During Hypoxia</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 1</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<mesh_term>Cyclooxygenase Inhibitors</mesh_term>
	<mesh_term>omega-N-Methylarginine</mesh_term>
	<mesh_term>Glucuronyl glucosamine glycan sulfate</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Diabetes type 1 without retinopathy Diabetic retinopathy Cardiovascular disease Lung disease Pregnancy Previous ocular disease other than retinal branch vein occlusion Previous treatment with medications influencing on the intraocular pressure or the metabolism of nitric oxide or prostaglandins</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>